KLOW Side Effects: What to Expect from the GHK-Cu + BPC-157 + TB-500 + KPV Stack
KLOW has a clean safety profile across all four peptides. Here's what side effects users actually report, which peptide causes what, and who should avoid the blend.
Side Effects by Component
Understanding which peptide is causing what helps you troubleshoot. Here's the breakdown:
BPC-157 — What It Can Cause
- Mild nausea (dose-dependent, usually at higher doses)
- Brief dizziness after injection
- Injection site soreness
TB-500 — What It Can Cause
- Mild fatigue in first 1–2 weeks
- Temporary headache
- Very rarely: mild nausea at high doses
GHK-Cu — What It Can Cause
- Injection site redness (mild, hours only)
- Temporary skin darkening at application site (topical only)
- Mild tingling at injection site
KPV — What It Can Cause
- One of the most well-tolerated peptides — side effects are extremely rare
- Mild injection site reaction
Overall KLOW Side Effect Profile
In practice, most people running KLOW don't separate out which peptide is responsible for what they feel — and for most users, the answer is: not much. The combination has a clean safety profile. The peptides in KLOW have overlapping mechanisms (healing, anti-inflammatory) and no known adverse interactions with each other.
- Spreading redness, warmth, or fever at injection site (infection)
- Severe or persistent nausea
- Allergic reaction: hives, swelling, difficulty breathing
Tips to Minimize Side Effects
- Start at a lower volume — if you're new to peptides, your first week at 50–75% of target dose lets your body adjust
- Rotate injection sites — abdomen, outer thigh, flank
- Inject slowly — reduces local irritation significantly
- Morning injection — avoids sleep disruption if you're sensitive
- Stay hydrated — reduces most injection-related systemic effects
Who Should Not Use KLOW
- People with active cancer (GHK-Cu promotes angiogenesis; BPC-157 has similar theoretical concern)
- Those with Wilson's disease or copper metabolism disorders (GHK-Cu component)
- Pregnant or breastfeeding women
- Competitive athletes subject to WADA testing (TB-500 is prohibited)
Frequently Asked Questions
Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. All peptides mentioned are research compounds not approved by the FDA for human use. Always consult a qualified healthcare provider before starting any peptide protocol. PeptideDeck may earn a commission from affiliate links at no additional cost to you.
